Product
High-intensity dose rosuvastatin + Ezetimibe
1 clinical trial
2 indications
Indication
Peripheral Artery DiseaseIndication
Polyvascular DiseaseClinical trial
Randomized Comparison of Efficacy and Safety of High-intensity Rosuvastatin/Ezetimibe Combination Versus Treat-to-target Rosuvastatin Monotherapy for Patients With Peripheral Artery or Polyvascular Disease (CARE-PVD Trial)Status: Not yet recruiting, Estimated PCD: 2026-05-06